Search

Your search keyword '"Moscinski, Lynn C."' showing total 347 results

Search Constraints

Start Over You searched for: Author "Moscinski, Lynn C." Remove constraint Author: "Moscinski, Lynn C."
347 results on '"Moscinski, Lynn C."'

Search Results

4. PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas

5. Retraction Notice to: Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas

13. Upfront Targeted Tyrosine Kinase Inhibitor Therapy Improves Outcome in Patients with Myeloid/Lymphoid Neoplasms with Eosinophilia

14. A microenvironment-mediated c-Myc/ miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas

25. Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated RUNX1 versus acute myeloid leukemia with myelodysplasia-related changes with mutated RUNX1

32. The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes

33. BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma Models

34. Pharmacoproteomics Identifies PLK1 As Vulnerability for Aggressive B-Cell Lymphomas

35. Prognostic Impact of MYC Oncoprotein Expression on Survival Outcome in Secondary AML Patients

36. Diagnosis of Myelodysplastic Syndromes and Related Conditions: Rates of Discordance between Local and Central Review in the NHLBI MDS Natural History Study

42. Association of EZH2 protein expression by immunohistochemistry in myelodysplasia related neoplasms with mutation status, cytogenetics and clinical outcomes

43. Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma

45. Monocyte Subset Analysis Accurately Distinguishes Chronic Myelomonocytic Leukemia (CMML) from Myelodysplastic Syndromes (MDS) and Is Associated with a Favorable MDS Prognosis

46. EZH2 Protein Expression Is Decreased in MDS and MDS/MPN and Correlated with EZH2 Mutation Status, Chromosomal 7 Abnormalities and Clinical Outcome

49. Association of EZH2 protein expression by immunohistochemistry in myelodysplasia related neoplasms with mutation status, cytogenetics and clinical outcomes.

50. TP53 and IDH2 Somatic Mutations Are Associated with Poor Outcomes Following Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome

Catalog

Books, media, physical & digital resources